Добавить новость
smi24.net
News in English
Апрель
2024

Новости за 23.04.2024

Miks Tumanovs (D) from JYP to JYP

Elite Prospects 

Date: 04/23/2024
Player: Miks Tumanovs (D)
From: JYP
To: JYP
Information: 2 years
Source: You need a free account to view Transfer URL Sign In/Up

Alexandre Mulle (F) from Caen to Caen

Elite Prospects 

Date: 04/23/2024
Player: Alexandre Mulle (F)
From: Caen
To: Caen
Information: 1 year
Source: You need a free account to view Transfer URL Sign In/Up

Samuele Pozzorini (D) from EHC Chur to EHC Chur

Elite Prospects 

Date: 04/23/2024
Player: Samuele Pozzorini (D)
From: EHC Chur
To: EHC Chur
Information: 1 year
Source: You need a free account to view Transfer URL Sign In/Up



Eriks Vitols (G) from KeuPa HT to JYP

Elite Prospects 

Date: 04/23/2024
Player: Eriks Vitols (G)
From: KeuPa HT
To: JYP
Source: You need a free account to view Transfer URL Sign In/Up

Jake Bolton (D) from Glasgow Clan

Elite Prospects 

Date: 04/23/2024
Player: Jake Bolton (D)
From: Glasgow Clan
Source: You need a free account to view Transfer URL Sign In/Up

Fabien Bourgeois (D) from Gap

Elite Prospects 

Date: 04/23/2024
Player: Fabien Bourgeois (D)
From: Gap
Source: You need a free account to view Transfer URL Sign In/Up

Jordan Mugnier (F) from Gap to Chamonix

Elite Prospects 

Date: 04/23/2024
Player: Jordan Mugnier (F)
From: Gap
To: Chamonix
Source: You need a free account to view Transfer URL Sign In/Up

Benjamin Eyre (D) from Morzine-Avoriaz

Elite Prospects 

Date: 04/23/2024
Player: Benjamin Eyre (D)
From: Morzine-Avoriaz
Source: You need a free account to view Transfer URL Sign In/Up

Mauro Frehner (F) from EHC Chur

Elite Prospects 

Date: 04/23/2024
Player: Mauro Frehner (F)
From: EHC Chur
Source: You need a free account to view Transfer URL Sign In/Up

Gender Eligibility Descriptions for Clinical Trials—Reply

Jamanetwork.com 

In Reply Our Research Letter analyzed free-text entries for the optional ClinicalTrials.gov data element, Gender Eligibility Description, as provided by study sponsors and investigators during trial registration. Of 1573 trials initiated between 2017 and 2022, nearly two-thirds described eligibility criteria based on sex at birth while another 11% did not contain terms for either gender identity or sex at birth, indicating confusion about the concept of gender identity. Frequent conflation of terms... Читать дальше...

Gender Eligibility Descriptions for Clinical Trials

Jamanetwork.com 

To the Editor A recent Research Letter by Dr Burton and colleagues revealed that almost two-thirds of the trials included in ClinicalTrials.gov reported applying gender-based eligibility between 2017 and 2022 when, in fact, sex-based eligibility was used instead. According to the National Institutes of Health, sex is considered a biological component, including chromosomes and gonads, and gender comprises social, cultural, and behavioral factors that influence a person’s self-identity. Sex and gender... Читать дальше...

Eosinophilic Gastrointestinal Disease

Jamanetwork.com 

This JAMA Insights Clinical Update discusses the symptoms, diagnosis, and management of eosinophilic gastrointestinal diseases.

Is Equity Being Traded for Access to Heart Transplant?

Jamanetwork.com 

Disparities in care and outcomes are common, complex problems and are well illustrated by heart failure, from the initial diagnosis to the treatment of advanced disease. In the US, Black individuals develop heart failure at a much younger age than individuals of other races, and the incidence for Black individuals is 50% higher than that for White individuals. Although the age-adjusted hospitalization rate for Black patients with heart failure in the US has decreased over the past 20 years, it was... Читать дальше...

Medicine—Both a Science (Care) and an Art (CARE)

Jamanetwork.com 

This Viewpoint discusses the concept of CARE (compassion, assistance, respect, and empathy) as a way physicians can practice the art of medicine in the current era of care that increasingly incorporates predictive analytics and artificial intelligence.





СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *